To confirm that the sequences were correct, we generated a synthetic mAb, called Oslo-1, incorporating the identified binding sequences, and tested if this mAb would bind to STEAP1 by staining a panel of tumor cell lines for flow cytometry. This evidence concerns the gene STEAP1 and neoplasm.